Zealand Pharma A/S
ZLDPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $48,981 | $21,263 | $9,042 | $6,177 |
| - Cash | $480 | $449 | $1,069 | $1,129 |
| + Debt | $392 | $119 | $443 | $787 |
| Enterprise Value | $48,892 | $20,933 | $8,416 | $5,835 |
| Revenue | $63 | $343 | $104 | $293 |
| % Growth | -81.7% | 229.6% | -64.5% | – |
| Gross Profit | $55 | $324 | $73 | $174 |
| % Margin | 87.4% | 94.4% | 70.5% | 59.4% |
| EBITDA | -$1,024 | -$658 | -$665 | -$712 |
| % Margin | -1,632.7% | -191.9% | -639.8% | -243.3% |
| Net Income | -$1,079 | -$704 | -$966 | -$1,018 |
| % Margin | -1,720.9% | -205.3% | -928.6% | -348% |
| EPS Diluted | -16.24 | -12.44 | -20.9 | -23.75 |
| % Growth | -30.5% | 40.5% | 12% | – |
| Operating Cash Flow | -$931 | -$426 | -$942 | -$1,212 |
| Capital Expenditures | -$13 | -$24 | -$12 | -$22 |
| Free Cash Flow | -$944 | -$449 | -$954 | -$1,234 |